# Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-versus-docetaxel-for-previously-treated-pd-l1-positive-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Roy S. Herbst,Paul Baas,Dong‐Wan Kim,Enriqueta Felip,José Luis Perez‐Gracia,Ji‐Youn Han,Julian R. Molina,Joo-Hang Kim,Catherine Dubos Arvis,Myung‐Ju Ahn,Margarita Majem,Mary J. Fidler,Gilberto de Castro,Marcelo Garrido,Gregory M. Lubiniecki,Yue Shentu,Ellie Im,Marisa Dolled‐Filhart,Edward B. Garon |
| Citations | 6,558 |
| DOI | 10.1016/s0140-6736(15)01281-7 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2198093519 |
| PMID | 26712084 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Myung‐Ju Ahn](https://scholariq.org/researchers/myung-ju-ahn/)
- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)
- [Dong‐Wan Kim](https://scholariq.org/researchers/dong-wan-kim/)
- [Edward B. Garon](https://scholariq.org/researchers/edward-b-garon/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.